Withaferin-A has been reported to extend the survival of SOD1 mutant ALS mice [11] and improved cognitive functions, induced autophagy, and attenuated TDP-43 proteinopathy in motor neurons through NF-κB inhibition, in various mice models of ALS [10,11,39]. Here, NFKB1 is linked to amyotrophic lateral sclerosis.